VDSCX
Price
$19.72
Change
+$0.14 (+0.72%)
Updated
Jul 9 closing price
Net Assets
340.82M
VTSAX
Price
$149.69
Change
+$0.95 (+0.64%)
Updated
Jul 9 closing price
Net Assets
1.91T
Interact to see
Advertisement

VDSCX vs VTSAX

Header iconVDSCX vs VTSAX Comparison
Open Charts VDSCX vs VTSAXBanner chart's image
Victory Diversified Stock C
Price$19.72
Change+$0.14 (+0.72%)
VolumeN/A
Net Assets340.82M
Vanguard Total Stock Mkt Idx Adm
Price$149.69
Change+$0.95 (+0.64%)
VolumeN/A
Net Assets1.91T
VDSCX vs VTSAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VDSCX vs. VTSAX commentary
Jul 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VDSCX is a Buy and VTSAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 1.91T vs. VDSCX (341M). VTSAX pays higher dividends than VDSCX: VTSAX (1.21) vs VDSCX (0.00). VDSCX was incepted earlier than VTSAX: VDSCX (23 years) vs VTSAX (25 years). VDSCX (4.02) is less costly to investors than VTSAX (0.04). VDSCX is a more actively managed with annual turnover of: 81.00 vs. VTSAX (2.00). VDSCX has a lower initial minimum investment than VTSAX: VDSCX (2500) vs VTSAX (3000). VTSAX annual gain was more profitable for investors over the last year : 12.27 vs. VDSCX (1.35). VTSAX return over 5 years is better than : 90.59 vs. VDSCX (26.24).
VDSCXVTSAXVDSCX / VTSAX
Total Expense Ratio2.020.045,050%
Annual Report Gross Expense Ratio4.020.0410,050%
Fund Existence23 years25 years-
Gain YTD7.4645.515135%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets341M1.91T0%
Annual Yield % from dividends0.001.21-
Returns for 1 year1.3512.2711%
Returns for 3 years18.8157.4533%
Returns for 5 years26.2490.5929%
Returns for 10 years-0.11195.09-0%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PTGX52.292.59
+5.21%
Protagonist Therapeutics
SONN4.640.17
+3.80%
Sonnet BioTherapeutics Holdings Inc
APP352.747.99
+2.32%
Applovin Corp
CNOB24.820.16
+0.65%
ConnectOne Bancorp
ENTA7.13-0.62
-8.00%
Enanta Pharmaceuticals